Literature DB >> 31776835

Circ-TFCP2L1 Promotes the Proliferation and Migration of Triple Negative Breast Cancer through Sponging miR-7 by Inhibiting PAK1.

Qian Wang1, Zhouxiao Li2, Yun Hu3, Wubin Zheng1, Weiwei Tang1, Changyuan Zhai4, Zhutong Gu5, Jing Tao6, Hanjin Wang7.   

Abstract

CircRNAs are essential factors that have been verified to regulate various forms of carcinogenesis. However, the role of circRNAs in triple negative breast cancer (TNBC) tumourigenesis is not well clarified. In this study, we explored the circRNA expression profiles and possible modulation mechanism of circRNAs on triple negative breast cancer tumourigenesis. We used three pairs of triple negative breast cancer tissues and adjacent noncancerous tissues to perform a human circRNA microarray for screening of circRNA expression patterns in TNBC. The results showed that circ-TFCP2L1 was significantly up-regulated in TNBC tissues and cells, tending to have a shorter disease-free survival of TNBC patients. In vitro loss-of-function experiments showed that knockdown of circ-TFCP2L1 significantly suppressed the proliferation and migration of TNBC cells. Moreover, the results showed that the proliferation and migration capabilities and PAK1 expression in TNBC cells treated with si-circ-TFCP2L1 + miR-7 mimics were significantly suppressed compared with the normal group. Therefore, circ-TFCP2L1 was identified as a sponge of miR-7 functionally targeting PAK1 and further promoting the proliferation and migration of TNBC cells. Taken together, the results from our study reveal a novel regulatory mechanism and offer novel insight into the role of circ-TFCP2L1 in progression of triple negative breast cancer.

Entities:  

Keywords:  Microarray; Migration; Proliferation; Sponge; circRNAs

Mesh:

Substances:

Year:  2019        PMID: 31776835     DOI: 10.1007/s10911-019-09440-4

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  2 in total

Review 1.  Circular RNA: an emerging key player in RNA world.

Authors:  Xianwen Meng; Xue Li; Peijing Zhang; Jingjing Wang; Yincong Zhou; Ming Chen
Journal:  Brief Bioinform       Date:  2017-07-01       Impact factor: 11.622

2.  Circular RNA hsa_circ_0006848 Related to Ribosomal Protein L6 Acts as a Novel Biomarker for Early Gastric Cancer.

Authors:  Jun Lu; Peng-Yang Zhang; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Ping Li; Chao-Hui Zheng; Chang-Ming Huang
Journal:  Dis Markers       Date:  2019-09-02       Impact factor: 3.434

  2 in total
  5 in total

Review 1.  Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.

Authors:  Zahra Foruzandeh; Davood Ghavi Dorabadi; Farzaneh Sadeghi; Fatemeh Zeinali-Sehrig; Mohammad Zaefizadeh; Yazdan Rahmati; Mohammad Reza Alivand
Journal:  Mol Biol Rep       Date:  2022-05-10       Impact factor: 2.742

2.  Circ_LDLR Knockdown Suppresses Progression of Hepatocellular Carcinoma via Modulating miR-7/RNF38 Axis.

Authors:  Yuming Jia; Shengchao Li; Meng Zhang; Zhilei Zhang; Chao Wang; Chong Zhang; Wuhan Yang; Li Peng; Zhuo Xu
Journal:  Cancer Manag Res       Date:  2021-01-13       Impact factor: 3.989

Review 3.  Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer.

Authors:  Lijuan Lyu; Shizhen Zhang; Yujiao Deng; Meng Wang; Xinyue Deng; Si Yang; Ying Wu; Zhijun Dai
Journal:  J Hematol Oncol       Date:  2021-03-06       Impact factor: 17.388

Review 4.  MiR-7 in Cancer Development.

Authors:  Petra Korać; Mariastefania Antica; Maja Matulić
Journal:  Biomedicines       Date:  2021-03-23

Review 5.  The biogenesis, function and clinical significance of circular RNAs in breast cancer.

Authors:  Yan Zeng; Yutian Zou; Guanfeng Gao; Shaoquan Zheng; Song Wu; Xiaoming Xie; Hailin Tang
Journal:  Cancer Biol Med       Date:  2021-06-10       Impact factor: 4.248

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.